40 employees
Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer.
2000
$489K
from 1 investors over 1 rounds
Galectin Therapeutics raised $489K on February 10, 2010
Investors: National Institutes of Health